Access to diagnostic evaluation and treatment for dementia in Europe

被引:118
作者
Waldemar, Gunhild
Phung, Kieu T. T.
Burns, Alistair
Georges, Jean
Hansen, Finn Ronholt
Iliffe, Steven
Marking, Christine
Rikkert, Marcel Olde
Selmes, Jacques
Stoppe, Gabriela
Sartorius, Norman
机构
[1] Copenhagen Univ Hosp, Rigshosp, Memory Disorder Res Grp, Dept Neurol,Neurosci Ctr, DK-2100 Copenhagen, Denmark
[2] Univ Manchester, Manchester, Lancs, England
[3] Copenhagen Univ Hosp, Dept Med C, Geriatr Sect, Gentofte, Denmark
[4] Royal Free & UCL Med Sch, Ctr Aging Populat Studies, Dept Primary Care & Populat Sci, London, England
[5] Univ Nijmegen, Med Ctr, Dept Geriatr, Alzheimer Ctr Nijmegen, Nijmegen, Netherlands
[6] Univ Basel, Hosp Psychiat, Basel, Switzerland
关键词
dementia; Alzheimer's disease; diagnosis; diagnostic evaluation; diagnostic assessment; early diagnosis; pharmacological treatment; early treatment; QUALITY STANDARDS SUBCOMMITTEE; MANAGING ALZHEIMERS-DISEASE; MILD COGNITIVE IMPAIRMENT; GENERAL-PRACTITIONERS; EARLY RECOGNITION; PRIMARY-CARE; PRACTICE PARAMETER; GUIDELINES; MANAGEMENT; PREVALENCE;
D O I
10.1002/gps.1652
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
This paper reviews and discusses existing barriers to diagnosis and treatment for patients with dementia in Europe as well as approaches to overcome these barriers. The barriers to care are manifold, being present at all levels in each society and between countries in Europe. Multilevel and multifaceted strategies are needed to improve diagnosis and treatments for all patients with cognitive complaints. A multidisciplinary approach based on close collaboration between GPs and specialised memory clinics may be the ideal model for early accurate diagnosis and subsequently early pharmacological and psychosocial interventions. For all healthcare professionals, there should be specialised training in dementia and frequently updated practice guidelines to provide the framework for standards of care. Culture-sensitive strategies to promote public knowledge and destigmatize dementia are essential. Policy makers and authorities should be made aware of the benefits of early access to diagnosis and treatment. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 60 条
  • [1] Interventions to reduce: The burden of caregiving for an adult with dementia: A meta-analysis
    Acton, GJ
    Kang, J
    [J]. RESEARCH IN NURSING & HEALTH, 2001, 24 (05) : 349 - 360
  • [2] Areosa S. A., 2005, COCHRANE DB SYST REV, V2005, pCD003154, DOI [10.1002/14651858.CD003154.pub4, DOI 10.1002/14651858.CD003154.pub4]
  • [3] Overlap between neurodegenerative disorders
    Armstrong, RA
    Lantos, PL
    Cairns, NJ
    [J]. NEUROPATHOLOGY, 2005, 25 (02) : 111 - 124
  • [4] Belmin Joel, 2003, Presse Med, V32, pS9
  • [5] Donepezil for dementia due to Alzheimer's disease
    Birks, Jacqueline S.
    Harvey, Richard J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (06):
  • [6] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Evans, John Grimley
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [7] Boomsma L J, 2004, Ned Tijdschr Geneeskd, V148, P1191
  • [8] Screening for dementia in primary care: A summary of the evidence for the US Preventive Services Task Force
    Boustani, M
    Peterson, B
    Hanson, L
    Harris, R
    Lohr, KN
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (11) : 927 - 937
  • [9] Bridges-Webb C, 2003, CARE PATIENTS DEMENT
  • [10] Bryans Michelle, 2003, Br J Nurs, V12, P1029